Pembrolizumab

Introduction

Pembrolizumab is a prescription immunotherapy drug used to treat various types of cancers, including melanoma, lung cancer, and head and neck cancers. It belongs to a class of medications known as monoclonal antibodies and works by enhancing the body’s immune response against cancer cells. It is administered through intravenous injection and is often used when other treatments have not worked or are no longer effective. Pembrolizumab is usually given in a clinical setting under strict medical supervision.

Uses of Pembrolizumab

• Non-small cell lung cancer (NSCLC)
• Melanoma (skin cancer)
• Head and neck squamous cell carcinoma
• Classical Hodgkin lymphoma
• Urothelial carcinoma (bladder cancer)
• Colorectal cancer with specific genetic markers (MSI-H/dMMR)
• Gastric and esophageal cancer
• Cervical cancer
• Hepatocellular carcinoma (liver cancer)

How Pembrolizumab Works

Pembrolizumab works by blocking the PD-1 (programmed death receptor-1) pathway, which cancer cells use to hide from immune cells. By inhibiting this pathway, it helps activate T-cells to detect and destroy cancer cells more effectively, boosting the body’s natural immune response.

Benefits of Pembrolizumab

• Improves survival rates in various cancers
• Targets cancer cells specifically without harming normal cells
• Boosts the body’s immune system to fight cancer
• Less toxic compared to traditional chemotherapy
• Can be effective in hard-to-treat and advanced cancers

How to Take Pembrolizumab

Pembrolizumab is administered as an intravenous infusion in a hospital or clinic. The usual dose is given once every 3 or 6 weeks, depending on your condition and response to treatment. Always follow your doctor’s instructions. Do not self-administer. Your doctor may conduct regular tests to monitor your response and adjust the dose if needed.

Type of Dosage Available

• 100 mg/4 mL injection (intravenous use only)
• Infusion solution for hospital administration

Side Effects of Pembrolizumab

• Fatigue
• Diarrhea
• Skin rash or itching
• Nausea
• Decreased appetite
• Cough or breathing difficulties
• Fever and chills
• Thyroid problems or hormone imbalance
• Inflammation of lungs, liver, or other organs (rare but serious)

Safety Advice

• Inform your doctor about any pre-existing medical conditions.
• Not recommended during pregnancy or breastfeeding.
• Regular blood tests may be required to monitor organ function.
• Use caution if you have autoimmune diseases.
• Avoid live vaccines during treatment.
• Inform your doctor if you are taking any immunosuppressants or steroids.

Frequently Asked Questions (FAQs)

Q: What is Pembrolizumab used for?
A: Pembrolizumab is used to treat various types of cancers such as lung cancer, melanoma, head and neck cancer, and more.

Q: How is Pembrolizumab administered?
A: It is given as an intravenous infusion by a healthcare professional, usually every 3 or 6 weeks.

Q: Are there any serious side effects?
A: Yes, although rare, it can cause inflammation in organs like the lungs, liver, or intestines, requiring immediate medical attention.

Q: Can pregnant women use Pembrolizumab?
A: No, it is not recommended during pregnancy as it may harm the unborn baby.

Q: Can Pembrolizumab cure cancer?
A: Pembrolizumab does not cure cancer but can help control or reduce the spread of cancer in some patients, improving quality of life and survival time.